GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Renascience Inc (TSE:4889) » Definitions » Debt-to-Revenue

Renascience (TSE:4889) Debt-to-Revenue : N/A (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Renascience Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Renascience's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円0.0 Mil. Renascience's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円365.6 Mil. Renascience's annualized Revenue for the quarter that ended in Sep. 2024 was 円0.0 Mil.


Renascience Debt-to-Revenue Historical Data

The historical data trend for Renascience's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renascience Debt-to-Revenue Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Revenue
5.28 2.27 1.43 3.08 1.83

Renascience Quarterly Data
Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 3.26 N/A 1.21 N/A

Competitive Comparison of Renascience's Debt-to-Revenue

For the Medical Devices subindustry, Renascience's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renascience's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Renascience's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Renascience's Debt-to-Revenue falls into.


;
;

Renascience Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Renascience's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 356.1) / 194.165
=1.83

Renascience's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 365.577) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Renascience Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Renascience's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Renascience Business Description

Traded in Other Exchanges
N/A
Address
2-3-6 Nihombashi-Honcho, Chuo-ku, Tokyo, JPN, 103-0023
Renascience Inc is engaged in the research and development of new medical solutions by utilizing various modalities such as pharmaceuticals, medical devices, artificial intelligence and others to solve problems in the medical setting.

Renascience Headlines

No Headlines